Related Experiment Video
Updated: Aug 9, 2026
10:27
Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
A Case Report of a Patient With Recalcitrant Pemphigus Vulgaris Treated With Rituximab
Mahlatse Cordelia Kgokolo1, Lesedi Makgwethele Nevondo2, Michaela Beetge3
1Department of Dermatology, School of Medicine, Faculty of Health Sciences University of Pretoria Pretoria South Africa.
Clinical Case Reports
|August 2, 2026
Abstract:
Pemphigus vulgaris may demonstrate differential treatment responses across disease sites. In this case, cutaneous lesions responded to high-dose corticosteroids, whereas refractory oral disease required rituximab to achieve remission, highlighting the need for individualized, multimodal therapy to achieve sustained disease control.
